ATAI Life Sciences BV (ATAI) stock news · rev $4.1M
ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
This ATAI news page leads with what ATAI Life Sciences BV filed — not a scraped headline mill.
No cached 8-K sentence for ATAI yet. We will not pad this page with generic market recap.
Latest reported ATAI revenue for 2025-12-31 was $4.1M. Net income was -$660.0M. Revenue was up 1227.6% from 2024-12-31 to 2025-12-31. ATAI currently screens at market cap $555.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ATAI stock page; for the tape open the quote page.
ATAI stock news FAQ
What are ATAI's latest revenue and net income?
Latest cached ATAI Life Sciences BV (ATAI) revenue for Dec 31, 2025 was $4.1M. Net income was -$660.0M. Statements: https://lician.com/financials/atai
How did ATAI revenue change from the prior cached period?
Cached ATAI Life Sciences BV (ATAI) revenue was up 1227.6% from $308.0K (Dec 31, 2024) to $4.1M (Dec 31, 2025). Statements: https://lician.com/financials/atai
What is ATAI's market cap?
ATAI Life Sciences BV (ATAI) market cap is $555.8M on the latest cached fundamentals snapshot.
What kind of company is ATAI?
ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
Where is ATAI stock news listed?
Cached stock news for ATAI Life Sciences BV (ATAI) is listed at https://lician.com/news/atai. Filings: https://lician.com/sec/atai
Not investment advice.